Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 40 citing articles:

Genetic and biological hallmarks of colorectal cancer
Jiexi Li, Xingdi Ma, Deepavali Chakravarti, et al.
Genes & Development (2021) Vol. 35, Iss. 11-12, pp. 787-820
Open Access | Times Cited: 360
Innate lymphoid cells and cancer
Nicolas Jacquelot, Cyril Seillet, Éric Vivier, et al.
Nature Immunology (2022) Vol. 23, Iss. 3, pp. 371-379
Open Access | Times Cited: 115
First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial
Marion Thibaudin, Jean-David Fumet, Benoist Chibaudel, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 2087-2098
Open Access | Times Cited: 45
PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions
Giuseppe Ercolano, Alejandra Gomez‐Cadena, Nina Dumauthioz, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 65
Bridging Chronic Inflammation and Digestive Cancer: The Critical Role of Innate Lymphoid Cells in Tumor Microenvironments
Guanliang Shen, Qi Wang, Zhengrui Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 12, pp. 4799-4818
Open Access | Times Cited: 12
CD4+ T cells in antitumor immunity
Elena Montauti, David Y. Oh, Lawrence Fong
Trends in cancer (2024)
Open Access | Times Cited: 10
Emerging Paradigms in Type 2 Immunity
Hamida Hammad, Nincy Debeuf, Helena Aegerter, et al.
Annual Review of Immunology (2022) Vol. 40, Iss. 1, pp. 443-467
Open Access | Times Cited: 29
Immunometabolic reprogramming, another cancer hallmark
Vijay Kumar, John H. Stewart
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
The role of group 3 innate lymphoid cell in intestinal disease
Minghui Li, Zehui Wang, Wei Jiang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
The Interplay Between Innate Lymphoid Cells and the Tumor Microenvironment
Laura Ducimetière, Marijne Vermeer, Sònia Tugues
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 31
Umbilical cord blood-derived ILC1-like cells constitute a novel precursor for mature KIR+NKG2A- NK cells
Sabrina B. Bennstein, Sandra Weinhold, Angela R. Manser, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 30
Eomes Expression Defines Group 1 Innate Lymphoid Cells During Metastasis in Human and Mouse
Riva Verma, Jun Zhi Er, Ren Wei Pu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 29
The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment
Elodie Renaude, Marie Kroemer, Romain Loyon, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 5, pp. 1673-1673
Open Access | Times Cited: 28
Systemic Interleukins’ Profile in Early and Advanced Colorectal Cancer
Paulina Czajka‐Francuz, Sylwia Cisoń-Jurek, Aleksander Czajka, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 124-124
Open Access | Times Cited: 26
The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update
Saade Abdalkareem Jasim, Roaa Salih Mahdi, Dmitry Olegovich Bokov, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5128-5148
Open Access | Times Cited: 16
Immunogenic chemotherapy: great potential for improving response rates
Xiaojun Huang, Qinghuan Ren, Leixiang Yang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Immune modulation via T regulatory cell enhancement: Disease‐modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)
Franziska Roth‐Walter, Ian M. Adcock, Cristina Benito‐Villalvilla, et al.
Allergy (2020) Vol. 76, Iss. 1, pp. 90-113
Open Access | Times Cited: 27
Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma
Charlée Nardin, Caroline Laheurte, E. Puzenat, et al.
Journal of Investigative Dermatology (2021) Vol. 142, Iss. 2, pp. 435-444
Open Access | Times Cited: 20
The unique role of innate lymphoid cells in cancer and the hepatic microenvironment
Sophie Curio, Gabrielle T. Belz
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 9, pp. 1012-1029
Open Access | Times Cited: 15
Crosstalk between epithelium, myeloid and innate lymphoid cells during gut homeostasis and disease
Sonia Ghilas, Ryan O’Keefe, Lisa A. Mielke, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
hTERT Promotes CRC Proliferation and Migration by Recruiting YBX1 to Increase NRF2 Expression
Chunli Gong, Huan Yang, Sumin Wang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 18
Innate lymphoid cells in colorectal cancer
Anne Marchalot, Jenny Mjösberg
Scandinavian Journal of Immunology (2022) Vol. 95, Iss. 4
Open Access | Times Cited: 13
Biology and therapeutic potential of human innate lymphoid cells
Sabrina B. Bennstein, Markus Uhrberg
FEBS Journal (2021) Vol. 289, Iss. 14, pp. 3967-3981
Open Access | Times Cited: 16
Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors
Costanza Maria Cristiani, Mariaelena Capone, Cinzia Garofalo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
The role of ILC subsets in cancer
Mélanie Bruchard, Hergen Spits
Seminars in Immunology (2022) Vol. 61-64, pp. 101654-101654
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top